GenoTwin
PrivateLast Round
Accelerator
Oct 14, 2022
Company Overview
GenoTwin is a biotechnology company that provides a genomics platform combining AI and computational biology to address infectious disease challenges and pathogen surveillance.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Healthcare Analytics, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Subscription SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
GenoTwin Comparables
Compare GenoTwin with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Barnwell Bio | 85% | |
| metaBIX Biotech | 81% | |
| DARO | 78% |
GenoTwin Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Oct 14, 2022 |
GenoTwin Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Plug and Play Tech Center | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Oct 14, 2022
Plug and Play Tech Center led the funding round.
GenoTwin Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about GenoTwin's valuation, stock price, and market status.
Is GenoTwin a public or private company?
GenoTwin is a private company.
What is the current stock price of GenoTwin?
GenoTwin is a private company with no public stock price. No recent secondary market data is available.
How much is GenoTwin worth (valuation)?
Valuation information for GenoTwin is not publicly available.
Can I buy GenoTwin stock?
GenoTwin shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was GenoTwin's last funding round?
GenoTwin's most recent funding round was Accelerator on October 14, 2022.
Who are the main investors in GenoTwin?
Key investors in GenoTwin include Plug and Play Tech Center.
Will GenoTwin IPO soon?
No public IPO plans have been announced for GenoTwin.
How can I track GenoTwin secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor GenoTwin's secondary market activity and sign up for updates.